Test Price
1,200 AED✅ Home Collection Available
Hair Transplant Panel A Test in UAE | 1200 AED | 2026 DHA Guidelines
تحليل لوحة زراعة الشعر (أ) في الإمارات | 1200 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & Clinical Authority
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy services across all Emirates.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance for comprehensive result interpretation by DHA-licensed specialists.
- ✓ Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
الملخص التنفيذي
لوحة تحليل زراعة الشعر الشاملة (أ) تقدم تقييماً تشخيصياً متكاملاً باستخدام تسلسل الإكسوم الكامل (WES) وتقنيات متقدمة متعددة. هذه اللوحة معتمدة من هيئة الصحة بدبي (DHA) ومطابقة للمواصفة ISO 9001:2015، وتوفر دقة تشخيصية تصل إلى 99.9%. تشمل الخدمة سحب عينات منزلية متميزة عبر سلسلة تبريد معتمدة، مع استشارة طبية هاتفية بعد صدور النتائج لضمان الفهم الكامل والتوجيه السريري الأمثل.
Clinical Overview
The Hair Transplant Panel A is a comprehensive, multi-methodology diagnostic assessment designed to evaluate systemic health, genetic predisposition, metabolic function, and coagulation status prior to hair restoration surgery. This panel integrates Whole Exome Sequencing (WES) with advanced biochemical, hematological, and coagulation assays to deliver a holistic pre-transplant risk profile, ensuring candidate suitability and optimizing surgical outcomes in full compliance with the 2026 UAE DHA regulatory framework.
تجمع لوحة تحليل زراعة الشعر (أ) بين تسلسل الإكسوم الكامل والتحاليل الكيميائية الحيوية والهرمونية وتقييم عوامل التخثر، مما يوفر ملفاً شاملاً للمخاطر قبل الجراحة لضمان سلامة المريض ونجاح العملية وفقاً لإرشادات هيئة الصحة بدبي.
| Feature | Our Test — Hair Transplant Panel A | Closest Alternative — Basic Pre-Op Panel |
|---|---|---|
| Diagnostic Precision | 99.9% Sensitivity — Multi-Platform Validation | ~85–90% — Single-Platform Limited |
| Core Methodology | WES + CLIA + HPLC + Hexokinase + Coagulation Photometry | Basic Spectrophotometry / Single Analyzer |
| Genetic Screening | Whole Exome Sequencing (WES) — Full Coverage | Not Included |
| Coagulation Profile | Comprehensive — PT, aPTT, INR, Platelet Function, PPP Analysis | PT/INR Only — Limited |
| Turnaround Time | Daily Reporting — Expedited | 3–5 Business Days |
| DHA Compliance | Full — Federal Decree-Law No. 41 of 2024 Compliant | Partial — May Not Meet 2026 Standards |
Physician Insight & Safety Protocol
Dr. Prabhakar Reddy (DHA License: 61713011) — “The Hair Transplant Panel A is not merely a screening checklist; it is a precision risk-stratification instrument. I strongly advise that every result be interpreted within the full clinical context — including family history, current pharmacotherapy, and scalp examination findings — because isolated laboratory values can mislead even experienced clinicians. My team is available to discuss any borderline or unexpected result to ensure safe, individualized surgical planning.”
⚠ Medication Safety Warning
Do not discontinue any prescribed medication without consulting your doctor. The Hair Transplant Panel A requires specific pre-test preparation — including temporary avoidance of iron supplements and overnight fasting — but all chronic medications should be reviewed by your prescribing physician prior to testing.
🚨 Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Do Not Proceed with Collection):
- Active scalp infection, folliculitis, or open wounds at collection or transplant site
- Known active autoimmune disorder with scalp involvement (e.g., active discoid lupus)
- Untreated or uncontrolled bleeding disorder (e.g., hemophilia, severe thrombocytopenia)
- Current chemotherapy or radiation therapy — requires oncologist clearance
- Pregnancy — elective transplant panels should be deferred
- Febrile illness (temperature >38.0°C) within 48 hours of scheduled collection
Emergency Red Flags (Seek Immediate Medical Attention):
- Signs of anaphylaxis post-collection: difficulty breathing, facial swelling, urticaria
- Acute hematoma or uncontrolled bleeding at venipuncture site
- Syncope (fainting) with loss of consciousness after blood draw
- Severe pallor, cold sweats, or tachycardia persisting >15 minutes post-collection
- Purulent discharge or spreading erythema at collection site >24 hours
Pre-Test Preparation & Specimen Logistics
Critical Pre-Test Instructions (MOHAP Standardized):
- Overnight Fasting: Minimum 8–10 hours of complete fasting prior to specimen collection. Water is permitted.
- Timing: Sample collection before 12:00 noon is strongly preferred to ensure circadian stability of hormone and metabolic markers.
- Iron Supplement Avoidance: Discontinue all iron-containing supplements for a minimum of 24 hours prior to specimen collection.
- Mandatory Forms: Duly filled Coagulation Requisition Form (Form 15) and Consent Form for HIV Testing with Pre-Test Counselling (Form 10 & 10A) are mandatory.
- Chronic Medications: Continue all prescribed medications unless specifically instructed otherwise by your physician.
Specimen requirements: 6 mL serum (3 SSTs), 2 mL plasma (1 Grey Top — Sodium Fluoride), 4 mL whole blood (1 Lavender Top — EDTA), 3 mL whole blood (1 Blue Top — Sodium Citrate). Detailed cold-chain and PPP preparation protocols provided at time of booking.
Patient FAQ & Clinical Guidance
Q: What exactly does the Hair Transplant Panel A include?
A: The Hair Transplant Panel A is a comprehensive multi-platform diagnostic protocol encompassing Whole Exome Sequencing (WES) for genetic susceptibility markers, complete coagulation profiling via photo-optical clot detection, comprehensive metabolic assessment using hexokinase and HPLC methodologies, complete blood count with differential by VCS technology, infectious disease screening, and specialized biochemical assays — all processed under ISO 9001:2015 certified laboratory conditions for maximum diagnostic fidelity. This breadth ensures that your hair transplant surgeon receives a 360-degree view of your systemic health, genetic risk factors, and hemostatic competence before proceeding with any surgical intervention.
س: ما الذي تتضمنه لوحة تحليل زراعة الشعر (أ) بالضبط؟
ج: تشمل اللوحة تسلسل الإكسوم الكامل (WES) لتحديد العلامات الجينية، وتقييماً كاملاً لعوامل التخثر باستخدام تقنية الكشف الضوئي البصري، وتحليلاً استقلابياً شاملاً، وفحصاً للأمراض المعدية، وعدداً كاملاً لمكونات الدم — جميعها معالجة في مختبر معتمد وفقاً لمعايير الأيزو.
Q: How quickly will I receive my Hair Transplant Panel A test results in the UAE?
A: Results for the Hair Transplant Panel A are reported daily with same-day availability for specimens collected before 09:00 AM, ensuring your hair transplant surgeon receives timely, actionable data for pre-operative clearance without unnecessary scheduling delays. The expedited turnaround is achieved through our integrated laboratory workflow that processes all components — from Whole Exome Sequencing to coagulation studies — in parallel rather than sequentially. You will receive a secure digital report accessible via our patient portal, and a DHA-licensed clinician is available for telephonic result interpretation within 24 hours of report release.
س: ما مدى سرعة الحصول على نتائج لوحة تحليل زراعة الشعر (أ) في الإمارات؟
ج: تصدر النتائج يومياً مع إمكانية الحصول عليها في نفس اليوم للعينات المسحوبة قبل الساعة التاسعة صباحاً، مما يضمن حصول الجراح على بيانات دقيقة وسريعة للموافقة على العملية دون تأخير.
Q: Is fasting absolutely required, and can I take my regular medications before the?
A: Overnight fasting of 8–10 hours is mandatory for the Hair Transplant Panel A because glucose, lipid, and certain hormone markers are exquisitely sensitive to recent food intake, and non-fasting specimens can produce falsely elevated values that may incorrectly flag surgical risk or necessitate costly retesting. Regarding medications: you must continue all prescribed chronic medications unless your doctor specifically instructs otherwise. However, iron supplements must be withheld for a minimum of 24 hours prior to collection. If you are on anticoagulants (e.g., warfarin, rivaroxaban, apixaban, clopidogrel), inform the phlebotomist at the time of collection and ensure your surgeon is aware, as these directly impact coagulation panel interpretation. Always consult your prescribing physician before making any medication adjustments.
س: هل الصيام ضروري قبل التحليل وهل يمكن تناول الأدوية المعتادة؟
ج: الصيام طوال الليل لمدة 8–10 ساعات إلزامي لدقة نتائج الجلوكوز والدهون والهرمونات. يجب الاستمرار في تناول الأدوية الموصوفة باستثناء مكملات الحديد التي يجب إيقافها لمدة 24 ساعة قبل الفحص، وينبغي إبلاغ طبيبك بأي مميعات للدم قبل إجراء التحليل.
Regulatory Compliance & Accreditation
ISO 9001:2015 Certified
Cert: INT/EGQ/2509DA/3139 — Laboratory Quality Management Systems
DHA Facility License
License No. 9834453 — Dubai Health Authority Regulated
UAE Data Protection
Full compliance with UAE PDPL — Personal Data Protection Law, and Federal Decree-Law No. 41 of 2024 (Art. 87)
This laboratory complies with the UAE CDS Law 2026 provisions regarding minors and vulnerable populations. All genetic data generated via Whole Exome Sequencing is stored, processed, and reported in strict accordance with UAE genomic data sovereignty regulations.
Clinical Specialists & Methodology
| Specialist | Clinical Intent | Relevance |
|---|---|---|
| Consultant Dermatologist | Assess scalp health, diagnose alopecia subtypes, identify inflammatory or cicatricial conditions affecting transplant viability | Primary clinical gatekeeper; determines transplant candidacy |
| Hair Transplant Surgeon | Evaluate donor-recipient area ratios, pre-operative risk stratification, surgical planning based on panel results | Directly acts on panel data for intraoperative decision-making |
| Clinical Pathologist | Interpret multi-methodology results, ensure quality control across WES, CLIA, HPLC, and coagulation platforms | Validates result integrity and clinically significant flag thresholds |
Primary Methodologies: Whole Exome Sequencing (WES) | Chemiluminescent Immunoassay (CLIA) | High Performance Liquid Chromatography (HPLC) | Hexokinase Method (Glucose) | Photo-Optical Clot Detection | Volume-Conductivity-Scatter (VCS) Hematology | Capillary Photometry / Westergren (ESR)
2026 ICD-10-CM Codes: L64.9 — Androgenic Alopecia, Unspecified | L65.9 — Nonscarring Hair Loss, Unspecified | Z41.8 — Encounter for Other Specified Pre-Procedural Examination
Primary LOINC Code: 81247-2 — Genetic Variant Analysis Panel | Component LOINC: 58410-2 (CBC Panel), 6301-6 (PT), 2345-7 (Glucose)
For appointments, home collection scheduling, or insurance verification, contact us via WhatsApp: +971 54 548 8731 | Home Collection Hours: 8:00 AM – 11:00 PM (All Emirates)
© 2026 DHA-Licensed Diagnostic Facility | ISO 9001:2015 Certified | Federal Decree-Law No. 41 of 2024 Compliant
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians